Pathophysiology: Absolute insulin deficiency leads to hyperglycemia, ketogenesis (metabolic acidosis), and osmotic diuresis. This results in profound water and electrolyte loss.
Key Electrolyte Changes:
Potassium (K+):
Serum K+: Can be normal or elevated on presentation despite a total body K+ deficit.
Mechanism of Hyperkalemia: Lack of insulin (which normally drives K+ into cells) and extracellular shift of K+ in exchange for H+ during acidosis.
Total Body Deficit: Caused by significant urinary losses from osmotic diuresis.
Clinical Pearl: Tx with insulin will drive K+ back into cells, causing a rapid drop in serum levels and potentially life-threatening hypokalemia. K+ replacement is critical, and insulin should be held if initial K+ is <3.3 mEq/L.
Sodium (Na+):
Serum Na+:Usually low (pseudohyponatremia) due to the osmotic effect of hyperglycemia drawing water into the extracellular space, diluting the sodium.
Correction Formula: For every 100 mg/dL increase in glucose above 100 mg/dL, add ~1.6 mEq/L to the measured Na+ to estimate the corrected value.
Phosphate (PO43-):
Serum PO43-: Often elevated initially due to extracellular shifts but reflects a total body deficit from urinary losses.
Clinical Pearl: Insulin therapy drives phosphate back into cells, which can lead to severe hypophosphatemia, impairing muscle function (including respiratory muscles) and ATP production.
Bicarbonate (HCO3-):
Serum HCO3-:Low (<18 mEq/L) due to titration by ketoacids, resulting in a high anion gap metabolic acidosis.
Hyperosmolar Hyperglycemic State (HHS)
Pathophysiology: Relative insulin deficiency allows for extreme hyperglycemia but is sufficient to prevent significant ketosis. The primary issue is profound dehydration from osmotic diuresis.
Key Electrolyte Changes:
Potassium (K+):
Similar to DKA, patients have a total body K+ deficit due to massive urinary losses.
Initial serum K+ can be normal or even high due to extracellular shifts from insulin deficiency and hyperosmolality.
Sodium (Na+):
Can be low, normal, or high.
Pseudohyponatremia is common due to extreme hyperglycemia.
However, if water loss exceeds sodium loss (which is typical in HHS), hypernatremia can occur.
Phosphate (PO43-) & Magnesium (Mg2+):
Total body stores are depleted due to prolonged osmotic diuresis.
Bicarbonate (HCO3-):
Usually normal or only mildly decreased (>15 mEq/L) as significant ketoacidosis is absent.
Effects of Insulin Therapy
Mechanism: Insulin activates the Na+/K+-ATPase pump, driving potassium into cells.
Key Effects:
↓ Serum K+: Insulin administration is a primary treatment for hyperkalemia but is the reason for iatrogenic hypokalemia during DKA/HHS treatment.
↓ Serum PO43- & Mg2+: Insulin also promotes the intracellular shift of phosphate and magnesium.
Refeeding Syndrome:
Relevant in malnourished patients (including those with uncontrolled DM) upon initiation of nutrition/insulin.
Insulin release stimulates the cellular uptake of glucose, K+, PO43-, and Mg2+ from the already depleted extracellular space.
This can lead to severe hypophosphatemia, hypokalemia, and hypomagnesemia, causing cardiac arrhythmias, muscle weakness, and respiratory failure.